PDGFRα- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features

Histopathology

Volumn 46, Issue 2, 2005, Pages 166-175

  Pauls, K ^a,b   Merkelbach Bruse, S ^a   Thal, D ^a   Buttner R ^a   Wardelmann, E ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

GIST; Kit; PDGFR

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR; DNA;

ADULT; AGED; ARTICLE; CELL TYPE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELL OF CAJAL; INTESTINE; MAJOR CLINICAL STUDY; MALE; MYENTERIC PLEXUS; NERVE CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHWANN CELL; SPINDLE CELL; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 14344256167     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02061.x     Document Type: Article

References (27)

1. Nakahara M, Isozaki K, Hirota S et al. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 1998; 115; 1090-1095.
2. Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279; 577-580.
3. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am. J. Pathol. 2002; 160; 1567-1572.
4. Heinrich MC, Corless CL, Duensing A et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299; 708-710.
5. Wardelmann E, Hrycek A, Merkelbach-Bruse S et al. Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epitheloid or mixed cell morphology in gastrointestinal stromal tumors. J. Mol. Diag. 2004; 6; 197-204.
6. Lasota J, Dansonka-Mieszkowska A, Sobin LH, Miettinen M. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab. Invest. 2004; 84; 874-883.
7. Wardelmann E, Neidt I, Bierhoff E et al. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod. Pathol. 2002; 15; 125-136.
8. Wardelmann E, Losen I, Hans V et al. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. Int. J. Cancer 2003; 106; 887-895.
9. Fletcher CD, Herman JJ, Corless C et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum. Pathol. 2002; 33; 459-465.
10. Bednar BMP. Histogenesis of benign pleomorphic mesenchymal tumors. Cesk Patol. 1986; 22; 241-244.
11. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 1998; 152; 1259-1269.
12. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod. Pathol. 2000; 13; 1134-1142.
13. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod. Pathol. 1998; 11; 728-734.
14. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am. J. Surg. Pathol. 1999; 23; 377-389.
15. Kumagai K, Uchida K, Miyamoto T et al. Three cases of canine gastrointestinal stromal tumors with multiple differentiations and c-kit-expression. J. Vet. Med. Sci. 2003; 65; 1119-1122.
16. Hart IK, Richardson WD, Heldin CH, Westermark B, Raff MC. PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 1989; 105; 595-603.
17. Schatteman GC, Morrison-Graham K, van Koppen A, Weston JA, Bowen-Pope DF. Regulation and role of PDGF receptor alpha-subunit expression during embryogenesis. Development 1992; 115; 123-131.
18. Eccleston PA, Collarini EJ, Jessen KR, Mirsky R, Richardson WD. Schwann cells secrete a PDGF-like factor: evidence for an autocrine growth mechanism involving PDGF. Eur. J. Neurosci. 1990; 2; 985-992.
19. Eccleston PA, Funa K, Heldin CH. Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia. Dev. Biol. 1993; 155; 459-470.
20. Fruttiger M, Karlsson L, Hall AC et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 1999; 126; 457-467.
21. Gnessi L, Emidi A, Jannini EA et al. Testicular development involves the spatiotemporal control of PDGFs and PDGF receptor's gene expression and action. J. Cell. Biol. 1995; 131; 1105-1121.
22. Vassbotn FS, Havnen OK, Heldin CH, Holmsen H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J. Biol. Chem. 1994; 269; 13874-13879.
23. Heldin P, Pertoft H, Nordlinder H, Heldin CH, Laurent TC. Differential expression of platelet-derived growth factor alpha- and beta-receptors on fat-storing cells and endothelial cells of rat liver. Exp. Cell. Res. 1991; 193; 364-369.
24. Barnhill RL, Xiao M, Graves D, Antoniades HN. Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo. Br. J. Dermatol. 1996; 135; 898-904.
25. Henriksen R, Funa K, Wilander E, Backstrom T, Ridderheim M, Oberg K. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res. 1993; 53; 4550-4554.
26. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am. J. Pathol. 1999; 154; 23-28.
27. Robinson TL, Sircar K, Hewlett BR, Chorneyko K, Riddell RH. Huizinga JD. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal. Am. J. Pathol. 2000; 156; 1157-1163.